O96160 AF NFT

Uncharacterized protein PF3D7_0207100

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeig75igq7nobp3t6isbcuvw7w66yapk7efynpjenofucvfsxwera6y/metadata.json
IPFS of structure file: 
bafybeicdn737wj6snmo5dd2sa4jydf7avzehnkwf6jwxmig76mjevdvmni/AF-O96160-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x78Cc7f9BF18AF8279e492D45EE7Fe9d7cC6f6D07
First NFT owner address (bech32): 
genesis10rx8lxl33tuz08jf94z7ullf6lxx7mg8844d65
Current NFT ID #536484 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
536484
Accession (UniProt):
O96160
Name::
Uncharacterized protein PF3D7_0207100
Experimental Method:
Predicted structure
Sequence source:
PLASMODIUM FALCIPARUM (ISOLATE 3D7)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT O96160 research and analysis (ICN3D with VR)

FASTA sequences

>sp|O96160|YPF14_PLAF7 Uncharacterized protein PF3D7_0207100 OS=Plasmodium falciparum (isolate 3D7) OX=36329 GN=PF3D7_0207100 PE=1 SV=2 MDSDKYKKFYVYNHGFTKQPFYERNLNDKGIHLKELKRLERVDEPRLYNNVDKIPNKKEIIYNNIKSNNIQVRVNQNNNEEKKKEEANYTCVNNKYVTLKNKVHVNKYVNNSNINKIKIVPIIKCSNYKIKNNPISHLKSNYENKFVKLSNFSNIKNGCSHKDNVINETMDQHKSEQLNNDNIKKLLYDYCIFREDTIKTKTNISYNKMNSFKDNEENINYMDNNNIKSNSSSYCSYSNKINQNNVNHTHLKTEFLNEKNSHTQNEQSIPLLDGLQNNHNSATKFHNNIYDNNNSLVNYKSDKGIDLHNKMMKIETDKNGIITLEKKKHDEKYYNNIFLNPLNDNSNNVVITTCDNKESYRNSTSDMINKIFEKMMNEKKNILKMKNFNDVIKKKITMAKEKILNSNSTINMKKVSFYNSKDEDLFNEKENSYKYGVKRENQEDINVIKNNMKRNNINIDNNDNINIIKNDSVSKNIHINNKKKRDDDFPFNNSAGLLLDFDLCKRKVLEILKNVQSSKKKNKILTNHNHSSDNQNCHSSDNQNCHSSDNQNCHSSDNQNCHSSDNQNCDSNACNKKDEEKKRKKKKIKKKNKMKNKSNNKSKNKRETKSKKISNNNNNDNMNNQCDNMGDQRINNENMDKQNVNIQNEGNGFNNNKNNNDLLNVYISPNMINHSLSSTCEKKNKEDNKMNDNKFLNSSSKMKIPEISTNNSNEKIVNVSNDEMLVYHNLTVLNVKEQGGVTEESSCIKRTYFVDQFYDSYNMRNEKITDDNMQVEDIYNVKENIKRTLKGDGHDDVKTNMLSEDNSYASGLWGNEINFISNNENCLNSYDISCDEKYIPNEEEQDEELCSNNILVKDIEEKKMCGKLFFEEICVFRINEKNEHGHENLRKNNHNDDTHKMYSSYENIQNINKQSTNPFCKKDEMEKSQGTNLFYDNYINSVDITKLELNKNCYQHINYEVQNLIKKENSYAAEMNVGLVFRKYIPILINLSCNYLLIKKNEKNVITCISYTNIIDVKIVKKSKKNKERFLFKIVYVFKKKEQKTEKNVTLLFRANLMEIFEKIKGRVDYCIIPNEDDKNIQLQDKKKKKGKKKKELQEEKMKKKKKTQEYVDIETVYEYVIEKYKRVHVLYLGRLLQIVEKLFKKYILKYSFHKLRIFYEYKIEMEKLKKNYIHCIYDISDKLEFLIKKKMQHYFNHIIINSYESSFINYQIKTNDMLYNLLLKEKSAYQNHLGKNYILILYKVLLSMYKKKMAIYFRSFVYNNIKVSKKKNAFAYTLTRVNSILVLYERRIKSFIFSKLKFNYDNVSYFCFTMYKIYLRRILFGYLRIRDNRINIKNVIEKNVYRLVKLISKISDNHKYNAFLKLQKYVYEQNEKKNKMICDNLIYANNELCNNLDKIAIEKGINQIDCLIKFKRKECLMKYFYTLKGPQINTERFYYCIRYCSIFSFVLNKIIQKKVQHIFFQFVLKTLQRNNKNRLTHAIKLLQVLVQKKEKKSVIDVLQLYDKYPYIFQYKDLTKIEVFVICVQNFVTLYNRKLLLNFLLKLHYLKYQEQFMKTYNGIGSIYKFVHVLDKKLMNTIRESFRVILQNDKFLREKMNMKMEQMDMKMEKIDVNMDQMDVKMEQMDVKMEQMDVKMKRMNKKKSKQIHVNYNNKAYSSSSPSPMLRYNKYKDMSSNSASLIKKYPFLIYNSEISPDCTTMADDKLSLPSNESVTHIFSYAYEDMDKIKKKIYDFNNKMSNVDL